BioCentury | Jan 28, 2016
Strategy

CIRM's endgame

...not a cause for industry reluctance. He said the company's latest IND, through its subsidiary Cell Cure Neurosciences Ltd....
BioCentury | Oct 19, 2015
Clinical News

OpRegen regulatory update

...early next year. Cell Cure is majority-owned by BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX, Alameda, Calif.). Cell Cure Neurosciences Ltd....
BioCentury | Nov 19, 2012
Company News

BioTime ophthalmic news

...BioTime will purchase 87,456 shares of its Cell Cure NeuroSciences Ltd. subsidiary in exchange for 906,735 BioTime shares at...
BioCentury | Oct 25, 2010
Company News

Cell Cure Neurosciences, Teva deal

...therefore eligible to share in milestones received by Cell Cure. Further terms were not disclosed. Cell Cure Neurosciences Ltd....
BioCentury | Jan 29, 2007
Company News

Allon, Amicus Therapeutics, Cell Cure Neurosciences Ltd., Intra-Cellular, Neurocrine, P2D Inc., Proneuron, ReNeuron, Sangamo, Wyeth, Michael J. Fox Foundation F

...Parkinson's disease (PD). Allon Therapeutics Inc . (TSX:NPC), Vancouver, B.C Amicus Therapeutics Inc., Cranbury, N.J. Cell Cure Neurosciences Ltd....
Items per page:
1 - 5 of 5
BioCentury | Jan 28, 2016
Strategy

CIRM's endgame

...not a cause for industry reluctance. He said the company's latest IND, through its subsidiary Cell Cure Neurosciences Ltd....
BioCentury | Oct 19, 2015
Clinical News

OpRegen regulatory update

...early next year. Cell Cure is majority-owned by BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX, Alameda, Calif.). Cell Cure Neurosciences Ltd....
BioCentury | Nov 19, 2012
Company News

BioTime ophthalmic news

...BioTime will purchase 87,456 shares of its Cell Cure NeuroSciences Ltd. subsidiary in exchange for 906,735 BioTime shares at...
BioCentury | Oct 25, 2010
Company News

Cell Cure Neurosciences, Teva deal

...therefore eligible to share in milestones received by Cell Cure. Further terms were not disclosed. Cell Cure Neurosciences Ltd....
BioCentury | Jan 29, 2007
Company News

Allon, Amicus Therapeutics, Cell Cure Neurosciences Ltd., Intra-Cellular, Neurocrine, P2D Inc., Proneuron, ReNeuron, Sangamo, Wyeth, Michael J. Fox Foundation F

...Parkinson's disease (PD). Allon Therapeutics Inc . (TSX:NPC), Vancouver, B.C Amicus Therapeutics Inc., Cranbury, N.J. Cell Cure Neurosciences Ltd....
Items per page:
1 - 5 of 5